CMND

Clearmind Medicine Inc. - Common Shares (CMND)

About Clearmind Medicine Inc. - Common Shares (CMND)

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.

Details

Daily high

Daily low

Price at open

52 Week High

$524.00

52 Week Low

$2.10

Market cap

4.4M

Dividend yield

0.00%

Volume

8,602

Avg. volume

5.0M

P/E ratio

-.02

Clearmind Medicine Inc. - Common Shares News